Castle Biosciences Inc (NASDAQ:CSTL) shares, rose in value on Friday, November 01, with the stock price down by -4.38% to the previous day’s close as strong demand from buyers drove the stock to $33.15.
Actively observing the price movement in the last trading, the stock closed the session at $34.67, falling within a range of $32.58 and $35.39. The value of beta (5-year monthly) was 1.028. Referring to stock’s 52-week performance, its high was $34.73, and the low was $15.28. On the whole, CSTL has fluctuated by 16.64% over the past month.
With the market capitalization of Castle Biosciences Inc currently standing at about $919.47 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2024-Nov-04.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 297.99M, with a low estimate of 60M and a high estimate of 88M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 79.84M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CSTL’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of CSTL currently trading nearly 3.13% and 8.45% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 57.00, while the 7-day volatility ratio is showing 5.67% which for the 30-day chart, stands at 4.89%. Furthermore, Castle Biosciences Inc (CSTL)’s beta value is 0.98, and its average true range (ATR) is 1.54.
A comparison of Castle Biosciences Inc (CSTL) with its peers suggests the former has fared considerably weaker in the market. CSTL showed an intraday change of -4.38% in last session, and over the past year, it grew by 111.15%%.
Data on historical trading for Castle Biosciences Inc (NASDAQ:CSTL) indicates that the trading volumes over the past 10 days have averaged 0.32 and over the past 3 months, they’ve averaged 410.37K. According to company’s latest data on outstanding shares, there are 27.41 million shares outstanding.
Nearly 6.32% of Castle Biosciences Inc’s shares belong to company insiders and institutional investors own 87.51% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.75 million shares as on 2024-10-15, resulting in a short ratio of 4.39. According to the data, the short interest in Castle Biosciences Inc (CSTL) stood at 650.00 of shares outstanding as of 2024-10-15; the number of short shares registered in 2024-09-13 reached 1.72 million. The stock has risen by 53.61% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CSTL stock heading into the next quarter.
